Kathy Lee-sepsick ^Leaders

Kathy Lee-Sepsick is the President and CEO of Femasys Inc., a company she founded in 2004 to revolutionize womens reproductive health through innovative, minimally invasive solutions. Her extensive career includes leadership roles at SaluMedica/MediZeus as Vice President and Novoste Corporation as Director, where she honed her expertise in medical technology and product development. Lee-Sepsick began her professional journey at Terumo Medical Corporation as a Senior Manager, building a strong foundation in the medical field. She holds an MBA in Marketing and Finance and a BS in Biochemistry from Rutgers University, equipping her with a robust skill set to navigate complex industry challenges. Recognized as a Top 100 Industry Leader by PharmaVoice in 2022, she is committed to advancing womens health, with several innovative products currently in clinical trials. Through her leadership at Femasys, Lee-Sepsick is dedicated to addressing long-neglected areas in reproductive health, driving significant change and progress in the industry.